Pendleton Todd

CIK 00017466361 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001746636

Recent Transactions

50 trades

Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-16$66.62/sh−1,959→ 53,356 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2025-12-15−5,233→ 0 total
Award
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2025-12-15+41,500→ 41,500 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-15$67.54/sh−6,056→ 55,315 total
Award
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2025-12-15+9,424→ 9,424 total
Award
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-15+18,848→ 56,138 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-12-15+5,233→ 61,371 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-02-19$83.75/sh−18,121→ 37,290 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2025-02-19−7,286→ 13,358 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2025-02-19$71.07/sh+7,286→ 55,411 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2024-12-16−4,593→ 0 total
Award
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-12-16+27,334→ 27,334 total
Award
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-12-16+15,550→ 51,244 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-12-16$79.18/sh−7,712→ 48,125 total
Award
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2024-12-16+7,775→ 7,775 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-12-16+4,593→ 55,837 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-28−8,499→ 20,644 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-28$68.40/sh+3,523→ 60,089 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-28$71.07/sh+8,499→ 56,566 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2024-02-28$81.69/sh−24,395→ 35,694 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2024-02-28−3,523→ 0 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-18$87.49/sh−1,153→ 48,067 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-15$88.60/sh−6,716→ 49,220 total
Award
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2023-12-15+24,262→ 24,262 total
Award
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2023-12-15+6,921→ 6,921 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2023-12-15−5,118→ 0 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-15+5,118→ 55,936 total
Award
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-12-15+13,842→ 50,818 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-08-31$68.40/sh+5,285→ 43,865 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (right to buy)
2023-08-31−5,285→ 3,523 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-08-31$84.41/sh−6,889→ 36,976 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (right to buy)
2023-02-22−7,927→ 8,808 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-02-22$64.60/sh+5,250→ 54,145 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (right to buy)
2023-02-22−5,209→ 0 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (right to buy)
2023-02-22−5,250→ 0 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-02-22$82.32/sh−28,701→ 38,580 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-02-22$62.43/sh+5,209→ 59,354 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2023-02-22$68.40/sh+7,927→ 67,281 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-12-19$70.80/sh−1,116→ 48,895 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2022-12-16−3,765→ 0 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-12-16$71.07/sh−3,020→ 50,011 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-12-16+3,765→ 53,031 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-12-15$73.17/sh−3,197→ 33,078 total
Award
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-12-15+16,188→ 49,266 total
Award
Dolby Laboratories, Inc.$DLB
Performance-Based Restricted Stock Unit
2022-12-15+8,094→ 8,094 total
Award
Dolby Laboratories, Inc.$DLB
Employee Stock Option (Right to Buy)
2022-12-15+29,143→ 29,143 total
Tax Payment
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-07-18$73.09/sh−1,513→ 36,275 total
Sale
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-05-19$75.80/sh−5,813→ 37,788 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Employee Stock Option (right to buy)
2022-05-19−5,813→ 16,735 total
Exercise/Conversion
Dolby Laboratories, Inc.$DLB
Class A Common Stock
2022-05-19$68.40/sh+5,813→ 43,601 total

Companies

Dolby Laboratories, Inc.
SVP, Chief Marketing Officer
$DLB

Recent Filings

Address

C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET

SAN FRANCISCO, CA, 94103

View on SEC.gov